GASTRIC MOTILITY DISORDER DRUG MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Regional Analysis

To learn more about this report, request sample copy

North America has established itself as the dominant region in the gastric motility disorder drug market and is projected to hold 37.9% of the market share in 2024. The large pharmaceutical industry presence and stringent regulations have created a strong culture of clinical research and drug development in the U.S. Major drug manufacturers have set up their headquarters and research centers in the country, driving significant investments into developing novel therapies. Furthermore, the higher healthcare spending and adoption of advanced drugs have supported the market growth over the years.

Asia Pacific has emerged as the fastest growing regional market. The rising geriatric population and growing cases of functional gastrointestinal disorders like gastroparesis have fueled the demand. Countries like China and India are focusing on enhancing local manufacturing capabilities through pharmaceutical industry incentives and reforms. This has attracted Western companies to collaborate with domestic players to tap into the lucrative market opportunities. Several global pharmaceutical companies have established manufacturing facilities and distribution networks in Asia Pacific to strengthen their regional market position.